Wall Street Access Asset Management »

Blueprint Medicines shares owned by Wall Street Access Asset Management

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Wall Street Access Asset Management from 13F filings

Historical chart of Wall Street Access Asset Management investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Wall Street Access Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Wall Street Access Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $39k 300 128.18

More positions owned by Wall Street Access Asset Management

Ishares Tr Core S&p 500 Etf Common Stock (IVV)
Berkshire Hathaway Inc Del Cl A Common Stock (BRK.A)
Apple Common Stock (AAPL)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Microsoft Corp Common Stock (MSFT)
Amazon Common Stock (AMZN)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)
American Balanced Fund Class F2 Mutual Fund (AMBFX)
Meta Platforms Inc Cl A Common Stock (META)
Alphabet Inc Cl A Common Stock (GOOGL)
Vanguard Index Fds Vanguard Value Etf Common Stock (VTV)
T. Rowe Price Capital Appreciation Fund Class I Mutual Fund (TRAIX)
American Capital Income Builder Fund Class F2 Mutual Fund (CAIFX)
American Growth Fund Of America Class F2 Mutual Fund (GFFFX)
Brown & Brown (BRO)

View all positions for Wall Street Access Asset Management

Top funds holding Blueprint Medicines

Wall Street Access Asset Management
Huntington National Bank

View all funds holding Blueprint Medicines